8-K ·Filed Jun 12, 2026

PHGE

BiomX Inc.
MIXED
Impact 5/10
Horizonweeks Processed3mo ago SEC0001213900-26-068026
8-K context-dependent: Items 3.01, 7.01
Actionable Insight ◆ Mixed

Track the company's progress on its compliance plan, particularly any capital raises or restructuring that could improve equity. Delisting risk remains significant if the plan fails, making PHGE a high-risk, event-driven trade. The extended timeline (2027) reduces near-term urgency.

DirectionMixed
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
PHGE ▼ -71.09% at T+60d
NEUTRAL call ✗ call lost -71.09% · α vs SPY -74.36% · entry $0.5362 → $0.1550
Entry anchored
Jun 12, 09:05 AM ET
via exchange tick
T+1d
+3.49%
call +3.49% · α +1.72%
$0.5549
settled 4mo ago
T+5d
-3.04%
call -3.04% · α -3.71%
$0.5199
settled 3mo ago
T+20d
-56.73%
call -56.73% · α -58.51%
$0.2320
settled 3mo ago
T+60d
-71.09%
call -71.09% · α -74.36%
$0.1550
settled 24d ago

Price Chart

Loading chart...

Executive Summary

BiomX Inc. received acceptance from NYSE American of its plan to regain compliance with continued listing standards, granting a plan period through September 25, 2027. The company had a stockholders' deficit of $(1.302 million) as of December 31, 2025 and losses in five recent fiscal years, leading to its non-compliance. While the plan acceptance provides a path to avoid delisting, the underlying financial weakness and high execution risk keep the outlook uncertain.

Key Facts

  • NYSE American accepted BiomX's compliance plan on June 10, 2026, with a plan period through September 25, 2027.
  • Non-compliance stemmed from stockholders' deficit of $1.302 million as of Dec 31, 2025 and losses from continuing operations in five recent fiscal years.
  • The company's stock will continue trading with a .BC (below compliance) indicator during the plan period.
  • If the company fails to regain compliance or make sufficient progress, delisting proceedings may be initiated.

Financial Impact

Stockholders' deficit of $1.302 million as of December 31, 2025, with ongoing losses from operations.

stockholdersEquity

Risk Factors

  • Failure to execute the compliance plan could lead to delisting and loss of liquidity.
  • Continued operating losses may further erode stockholders' equity and worsen compliance.
  • Going concern risk given historical losses and negative equity.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-068026
Document: ea029450701ex99-1.htm0001213900-26-068026
Document: 0001213900-26-068026-index-headers.html0001213900-26-068026
Document: 0001213900-26-068026-index.html0001213900-26-068026
Document: 0001213900-26-068026.txt0001213900-26-068026
20 reports for PHGE
Performance horizon
64% Hit rate 7 of 11 directional calls best @ T+20▲ +62.36%Jun 16, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access